| Thomas Roy Hogan, MD | |
|
425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401-4123 | |
| (715) 845-5505 | |
| (715) 848-2884 |
| Full Name | Thomas Roy Hogan |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 20 Years |
| Location | 425 Pine Ridge Blvd, Wausau, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376752147 | NPI | - | NPPES |
| 002739110 | Other | WI | MEDICARE RAILROAD |
| 002739110 | Other | WI | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | R7238 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspirus Wausau Hospital | Wausau, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Riverview Hospital And Clinics Inc | 4587658182 | 144 |
| Central Wisconsin Anesthesiology | 5597667097 | 46 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Aspirus Riverview Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295754844 PECOS PAC ID: 4587658182 Enrollment ID: O20040414000945 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Central Wisconsin Anesthesiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518999648 PECOS PAC ID: 5597667097 Enrollment ID: O20040805000454 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Bellin Anesthesia Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558318410 PECOS PAC ID: 1254357684 Enrollment ID: O20051014000796 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Anesthesia Management Solutions Of Wisconsin Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205301850 PECOS PAC ID: 5092052118 Enrollment ID: O20190129000172 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Roy Hogan, MD 425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401-4123 Ph: (715) 845-5505 | Thomas Roy Hogan, MD 425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401-4123 Ph: (715) 845-5505 |
News Archive
Alcohol consumption is a major risk factor for several cancers including head & neck, oesophageal and bowel cancer – as well as the more widely known links to breast and liver cancer – according to a new study funded by World Cancer Research Fund, and published this week in Nature Communications.
The National Nanotechnology Initiative (NNI) released today a Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy, a document that demonstrates the wide range of research activities, accomplishments, and collaborations of Federal agencies working toward the responsible development of nanotechnology.
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. That is the finding of a new study published in the December 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
As the Zika virus continues to spread rapidly across the globe, it might pose a particular risk to people previously infected with two related viruses, dengue and West Nile, researchers at the Icahn School of Medicine at Mount Sinai have found.
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.
› Verified 7 days ago
Nam D Doan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401 Phone: 715-845-5505 Fax: 715-848-2884 | |
Debra K Markwardt, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401 Phone: 715-845-5505 Fax: 715-848-2884 | |
Dr. William J Holm, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401 Phone: 715-845-5505 Fax: 715-848-2884 | |
Dr. Suzanne G.h. Low, Anesthesiology Medicare: Medicare Enrolled Practice Location: 6209 Lakeshore Dr., Wausau, WI 54401 Phone: 715-359-0299 Fax: 715-355-2159 | |
Robert M Mcgucken, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2727 Plaza Dr, Wausau, WI 54401 Phone: 715-847-3000 Fax: 715-847-3329 | |
Andrew G Drewry, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 425 Pine Ridge Blvd, Suite 211, Wausau, WI 54401 Phone: 715-845-5505 Fax: 715-848-2884 |